Meeting
2023 ASCO Genitourinary Cancers Symposium
Performance of a blood-based liquid biopsy test to detect PSMA expression on circulating tumor cells in men with metastatic prostate cancer.
Authors
Santosh Gupta
Epic Sciences, San Diego, CA
Santosh Gupta , Anis Hamid , Luisa Fernandez , Anupama Pasam , Ernest Lam , Alisa Tubbs , David Bourdon , Louise Emmett , Anthony M. Joshua , Michael S Hofman , Rick Wenstrup , Shahneen Sandhu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 256)
DOI
10.1200/JCO.2023.41.6_suppl.256
Abstract #
256
Poster Bd #
J13
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Santosh Gupta
Poster
2023 ASCO Annual Meeting
Circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with olaparib plus 177lutetium-prostate specific membrane antigen-617 (177Lu-PSMA-617) in the LuPARP trial.
First Author: Anis Hamid
Poster
2017 Genitourinary Cancers Symposium
Genomic mechanisms of resistance to neoadjuvant leuprolide plus abiraterone in locally advanced prostate cancer.
First Author: Adam G. Sowalsky
Poster
2022 ASCO Annual Meeting
Circulating tumour cells (CTCs) and PSMA PET correlates in the phase I PRINCE trial of 177Lu-PSMA-617 plus pembrolizumab for metastatic castration resistant prostate cancer (mCRPC).
First Author: Anis Hamid